C20ORF194 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.070170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.637800E-01
Normal-vs-Stage2
1.180570E-01
Normal-vs-Stage3
1.010330E-02
Normal-vs-Stage4
2.467600E-01
Stage1-vs-Stage2
2.956600E-01
Stage1-vs-Stage3
2.168300E-02
Stage1-vs-Stage4
5.207400E-01
Stage2-vs-Stage3
1.966780E-01
Stage2-vs-Stage4
8.484000E-01
Stage3-vs-Stage4
1.655790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.087800E-01
Normal-vs-AfricanAmerican
2.772400E-01
Normal-vs-Asian
9.401700E-02
Caucasian-vs-AfricanAmerican
5.029200E-01
Caucasian-vs-Asian
3.397600E-01
AfricanAmerican-vs-Asian
2.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.755900E-02
Normal-vs-Female
1.347950E-01
Male-vs-Female
5.643000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.705200E-01
Normal-vs-Age(41-60Yrs)
1.496210E-01
Normal-vs-Age(61-80Yrs)
1.096970E-01
Normal-vs-Age(81-100Yrs)
4.738300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.971200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.780000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.454400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.447610E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.721400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.503400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.006200E-02
Normal-vs-Daily Drinker
1.170190E-02
Normal-vs-Weekly Drinker
1.170150E-01
Normal-vs-Occasional Drinker
1.305010E-01
Normal-vs-Social Drinker
5.301800E-01
Non Drinker-vs-Daily Drinker
2.447200E-01
Non Drinker-vs-Weekly Drinker
5.740200E-01
Non Drinker-vs-Occasional Drinker
5.888000E-01
Non Drinker-vs-Social Drinker
3.642600E-01
Daily Drinker-vs-Weekly Drinker
1.198240E-01
Daily Drinker-vs-Occasional Drinker
1.217230E-01
Daily Drinker-vs-Social Drinker
1.373160E-01
Weekly Drinker-vs-Occasional Drinker
9.652000E-01
Weekly Drinker-vs-Social Drinker
5.952200E-01
Occasional Drinker-vs-Social Drinker
5.722600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.075600E-01
Normal-vs-Grade 2
1.357420E-01
Normal-vs-Grade 3
1.287850E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.534600E-01
Grade 1-vs-Grade 3
4.557400E-01
Grade 1-vs-Grade 4
2.075600E-01
Grade 2-vs-Grade 3
6.959400E-01
Grade 2-vs-Grade 4
1.357420E-01
Grade 3-vs-Grade 4
1.287850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.127400E-01
Normal-vs-NonDiabetic
7.349900E-02
Diabetic-vs-NonDiabetic
6.869400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.113000E-01
Normal-vs-NoPancreatitis
5.184200E-02
Pancreatitis-vs-NoPancreatitis
9.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.289600E-02
Normal-vs-N1
1.243760E-01
N0-vs-N1
7.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.862400E-02
Normal-vs-TP53-NonMutant
3.412200E-01
TP53-Mutant-vs-TP53-NonMutant
6.258800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
